PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
The national blood transfusion services in Namibia are operated by the Blood Transfusion Service of Namibia (NAMBTS) in Windhoek. NAMBTS became a recipient of USG support in FY04 through a direct funding Cooperative Agreement. Before PEFPAR, Namibia had no National Blood Policy, Strategic Plan to Strengthen the National Blood Program, nor National Guidelines on the Appropriate Clinical Use of Blood and Blood Products. Since then, National Guidelines on the Appropriate Clinical Use of Blood and Blood Products have been developed and a National Blood Policy has been drafted; the 5-Year Strategic Plan and legislative framework will follow. Also before PEPFAR, there was one blood collection and testing facility (Windhoek) and one blood bank facility in the northern region (Oshakati). Collection of blood in the Oshakati area was discontinued in 2003 due to the high prevalence of HIV and hepatitis. These 2 facilities were inadequate to meet the safe blood supply needs of a country as vast as Namibia.
With USG support, NAMBTS opened a second fixed donor site in Windhoek and a blood bank and donor clinic facility in Swakopmund; donor clinics in Oshakati were resumed in July 2006. Mobile Teams collect blood from other sites (e.g. schools). During FY06, an equipment upgrade for the Windhoek blood component laboratory improved the quality of the blood components produced.
In 2005 five blood transfusion staff were funded by the project and a part-time medical officer was hired in who has been actively involved in developing the Guidelines for the Appropriate Use of Blood and Blood Products and developing training programs to be provided to the medical community on appropriate use of blood. She has also provided much needed medical backup to the donor clinic in the selection of donors, to the blood bank in the provision of blood and blood products and to the doctors who use the products. An officer for quality management and training was hired by NAMBTS in 2005 and continues to provide and arrange training at all levels. He has been involved in the development of the National Blood Policy, the Clinical Guidelines for the Appropriate Use of Blood and Blood Products, and the proposed Standards for the Practice of Blood Transfusion in Namibia. The Quality Management System and the development of documented policies and procedures, the internal audit program etc. is also ongoing.
NAMBTS' capacity to supply units of blood increased from 18,000 in 2003 to 19,051 in 2005, with an estimated need of 22,000 units per year. To facilitate the design of more effective donor recruitment and retention campaigns, a KAP study was done in collaboration with WHO and the University of Namibia in 2005 with support from NAMBTS and MoHSS.
All donated blood is tested for HIV, syphilis, and hepatitis B and C. This testing is currently carried out by the South African National Blood Service in Johannesburg, South Africa, on behalf of NAMBTS because it was determined that this was the most cost-effective method of providing the safest blood possible (including NAT for HIV) to overcome the issues of prohibitive cost for local NAT and the lack of adequately trained local staff. However, this policy will be reviewed this year. HIV prevalence among blood donors from (period covered) is approximately 0.35%.
A survey of blood usage practices is ongoing; this survey is being conducted in collaboration with WHO, NAMBTS and the MoHSS. Appropriate NAMBTS staff received training in Quality Management, Supervisory/Management skills, pre- and post-donation counseling, training in cold chain management, general technical training and general donor clinic training; training is ongoing. The NAMBTS is funded through a system of cost recovery, with majority of the service fees being paid by the MOHSS since 80% of blood and blood products are supplied to the MoHSS. NAMBTS will focus on cost control methods to help improve financial sustainability.
USG support will be continued in FY07 for additional contracted personnel, to purchase needed equipment and supplies, and to provide training in blood donor recruitment and selection as well as management of a safe blood supply. Plans for strengthening infrastructure include the Windhoek renovation/construction, pending funding by GF Round 6. Training interventions are currently planned, including a program on component production, Supervisory/Management skills, specialized post-donation counseling, training of Namibia Institute of Pathology staff on blood group serology, crossmatch techniques, and quality management and cold chain management. In addition extensive training is
planned for the medical community on the Guidelines for the Appropriate Use of Blood and Blood Products and also on the development of Transfusion Committees. Emphasis areas during FY07 will include implementation of a new information system for the NAMBTS; implementation of a quality management system for the service; training of medical technicians and donor clinic staff; ongoing training of blood users in the appropriate use of blood and blood products; and implementation of a haemovigilance program.
